{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Cannabinoid receptor interacting protein 1 (CNRIP1), also known as CRIP1a, is emerging as a multifaceted modulator of CB1 receptor function that influences diverse processes in both the nervous system and peripheral tissues. Molecular studies demonstrate that CNRIP1 binds to the distal C‐terminus of the CB1 receptor, where it can attenuate constitutive as well as agonist‐stimulated G protein signaling—thereby affecting receptor desensitization, internalization, and downstream signal transduction."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n In neurons, such modulation is critical for fine‐tuning synaptic transmission, neuroprotection, and plasticity. Alterations in CNRIP1 expression have been linked to neuropsychiatric disorders; for example, viral‐mediated overexpression in the ventral hippocampus has been associated with enhanced dopaminergic activity and behavioral deficits reminiscent of schizophrenia."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role in mature neural circuits, CNRIP1 is essential during development. Studies in Xenopus laevis embryos reveal that its expression in the early animal region is critical for proper neural and eye formation, suggesting an instructive role during early neurodevelopment."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n In addition, CNRIP1 has been implicated in the regulation of pain circuitry via its interactions within key brainstem regions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n On the oncological front, aberrant epigenetic modifications of the CNRIP1 gene (such as promoter hypermethylation) have been documented in several malignancies—including intrahepatic cholangiocarcinoma and colorectal cancer—where reduced expression correlates with higher pathological grade, increased invasiveness, and poorer patient prognosis. This suggests a potential tumor suppressor role for CNRIP1 and highlights its utility as a diagnostic and prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, pharmacological interventions that modify CNRIP1 levels have been shown to impact hippocampal function; for instance, pyridoxine treatment can down-regulate CRIP1 levels, an effect that is associated with enhanced recognition memory and improved markers of neurogenesis in the dentate gyrus."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n Collectively, these findings position CNRIP1 as a key regulatory hub that not only governs CB1 receptor signaling and neuronal excitability but also plays roles in neurodevelopment, pain modulation, and tumor biology, underscoring its significance as both a mechanistic mediator and a potential therapeutic target"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "–."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Lawrence C Blume, Khalil Eldeeb, Caroline E Bass, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2014.11.006"}], "href": "https://doi.org/10.1016/j.cellsig.2014.11.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25446256"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25446256"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stephan Guggenhuber, Alan Alpar, Rongqing Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Struct Funct (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00429-015-1027-6"}], "href": "https://doi.org/10.1007/s00429-015-1027-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25772509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25772509"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Stephanie M Perez, Jennifer J Donegan, Angela M Boley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2018.11.006"}], "href": "https://doi.org/10.1016/j.schres.2018.11.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30522798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30522798"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiaona Zheng, Toshiyasu Suzuki, Chika Takahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "cnrip1 is a regulator of eye and neural development in Xenopus laevis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Cells (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/gtc.12225"}], "href": "https://doi.org/10.1111/gtc.12225"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25652037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25652037"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Enza Palazzo, Livio Luongo, Giulia Bellini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "CNS Neurol Disord Drug Targets (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/187152712800269731"}], "href": "https://doi.org/10.2174/187152712800269731"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22483283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22483283"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Diyu Chen, Hao Wu, Xiaode Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin-Dependent Pyruvate Kinase M2 Ubiquitination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.31561"}], "href": "https://doi.org/10.1002/hep.31561"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32955740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32955740"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.27707"}], "href": "https://doi.org/10.1002/hep.27707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25644509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25644509"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hyo Young Jung, Dae Won Kim, Sung Min Nam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pyridoxine improves hippocampal cognitive function via increases of serotonin turnover and tyrosine hydroxylase, and its association with CB1 cannabinoid receptor-interacting protein and the CB1 cannabinoid receptor pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Gen Subj (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagen.2017.09.006"}], "href": "https://doi.org/10.1016/j.bbagen.2017.09.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28935605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28935605"}]}]}]}